Effects of melanocortin receptor ligands on ethanol intake and opioid peptide levels in alcohol-preferring AA rats

Brain Research Bulletin

Volumn 59, Issue 2, 2002, Pages 97-104

  Ploj, Karolina ^a   Roman, Erika ^a   Kask, Ants ^b   Hyytiä, Petri ^c   Schiöth, Helgi B ^a   Wikberg, Jarl E S ^a   Nylander, Ingrid ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF TARTU   (Estonia)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Alcohol preferring rats; Dynorphin B; HS014; Met enkephalin Arg6Phe7; MTII

Indexed keywords

ALCOHOL; BETA INTERMEDIN[11-22][11 (N ACETYLCYSTEINE) 14 [3 (2 NAPHTHYL) DEXTRO ALANINE] 18 CYSTEINE 22 ASPARTIC ACID AMIDE] 11,18 CYCLIC DISULFIDE; DYNORPHIN B; HORMONE RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR STIMULATING AGENT; LIGAND; MELANOCORTIN RECEPTOR; METENKEPHALIN[6 ARGININE 7 PHENYLALANINE]; OPIATE PEPTIDE;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN REGION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLUID INTAKE; FOOD INTAKE; HYPOPHYSIS; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ALCOHOL DRINKING; ALPHA-MSH; ANIMALS; EATING; FEMALE; LIGANDS; OLIGOPEPTIDES; OPIOID PEPTIDES; PEPTIDES, CYCLIC; RATS; RECEPTORS, CORTICOTROPIN; RECEPTORS, MELANOCORTIN;

EID: 0037202035     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(02)00844-4     Document Type: Article

References (47)

1. Adan R.A., Gispen W.H. Brain melanocortin receptors: From cloning to function. Peptides. 18:1997;1279-1287.
2. Al-Obeidi F., Castrucci A.M., Hadley M.E., Hruby V.J. Potent and prolonged acting cyclic lactam analogues of α-melanotropin: Design based on molecular dynamics. J. Med. Chem. 32:1989;2555-2561.
3. Alvaro J.D., Tatro J.B., Duman R.S. Melanocortins and opiate addiction. Life Sci. 61:1997;1-9.
4. Alvaro J.D., Tatro J.B., Quillan J.M., Fogliano M., Eisenhard M., Lerner M.R., Nestler E.J., Duman R.S. Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction. Mol. Pharmacol. 50:1996;583-591.
5. Angulo J.A., McEwen B.S. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Brain Res. Rev. 19:1994;1-28.
6. Benjamin D., Grant E.R., Pohorecky L.A. Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats. Brain Res. 621:1993;137-140.
7. Christensson-Nylander I., Herrera-Marschitz M., Staines W., Hökfelt T., Terenius L., Ungerstedt U., Cuello C., Oertel W.H., Goldstein M. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies. Exp. Brain Res. 64:1986;169-192.
8. Christensson-Nylander I., Nyberg F., Ragnarsson U., Terenius L. A general procedure for analysis of proenkephalin B derived opioid peptides. Regul. Pept. 11:1985;65-76.
9. Contreras P.C., Takemori A.E. Antagonism of morphine-induced analgesia, tolerance and dependence by alpha-melanocyte-stimulating hormone. J. Pharmacol. Exp. Ther. 229:1984;21-26.
10. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 85:1988;5274-5278.
11. Eriksson K. Genetic selection for voluntary alcohol consumption in the albino rat. Science. 159:1968;739-741.
12. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:1997;165-168.
13. Gianoulakis C. Implications of endogenous opioids and dopamine in alcoholism: Human and basic science studies. AlcoholAlcohol. Suppl. 1:1996;33-42.
14. Gispen W.H., Buitelaar J., Wiegant V.M., Terenius L., De Wied D. Interaction between ACTH fragments, brain opiate receptors and morphine-induced analgesia. Eur. J. Pharmacol. 39:1976;393-397.
15. Grill H.J., Ginsberg A.B., Seeley R.J., Kaplan J.M. Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight. J. Neurosci. 18:1998;10128-10135.
16. Herrera-Marschitz M., Christensson-Nylander I., Sharp T., Staines W., Reid M., Hökfelt T., Terenius L., Ungerstedt U. Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis. Exp. Brain Res. 64:1986;193-207.
17. Heyser C.J., Roberts A.J., Schulteis G., Koob G.F. Central administration of an opiate antagonist decreases oral ethanol self-administration in rats. Alcohol. Clin. Exp. Res. 23:1999;1468-1476.
18. Hohmann J.G., Teal T.H., Clifton D.K., Davis J., Hruby V.J., Han G., Steiner R.A. Differential role of melanocortins in mediating leptin's central effects on feeding and reproduction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:2000;50-59.
19. Hyytiä P., Sinclair J.D. Differential reinforcement and diurnal rhythms of lever pressing for ethanol in AA and Wistar rats. Alcohol. Clin. Exp. Res. 14:1990;375-379.
20. Jacquet Y.F. Opiate effects after adrenocorticotropin or beta-endorphin injection in the periaqueductal gray matter of rats. Science. 201:1978;1032-1034.
21. Kask A., Rago L., Mutulis F., Pahkla R., Wikberg J.E., Schiöth H.B. Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats. Biochem. Biophys. Res. Commun. 245:1998;90-93.
22. Koob G.F., Nestler E.J. The neurobiology of drug addiction. J. Neuropsychiatry Clin. Neurosci. 9:1997;482-497.
23. 4 receptor mediates α-MSH induced release of nucleus accumbens dopamine. Neuroreport. 12:2001;2155-2158.
24. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Anatomy of CNS opioid receptors. Trends Neurosci. 11:1988;308-314.
25. 4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8:1994;1298-1308.
26. Mucha R.F., van Ree J.M. Infusion of gamma 2-MSH produce a conditioned taste aversion in morphine-dependent rats. Psychopharmacology. 99:1989;140-142.
27. Nylander I., Hyytiä P., Forsander O., Terenius L. Differences between alcohol-preferring (AA) and alcohol-avoiding (ANA) rats in the prodynorphin and proenkephalin systems. Alcohol. Clin. Exp. Res. 18:1994;1272-1279.
28. O'Malley S.S., Jaffe A.J., Chang G., Schottenfeld R.S., Meyer R.E., Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Arch. Gen. Psychiatry. 49:1992;881-887.
29. Ploj K., Roman E., Gustavsson L., Nylander I. Basal levels and alcohol-induced changes in nociceptin/orphanin FQ, dynorphin, and enkephalin levels in C57BL/6J mice. Brain Res. Bull. 53:2000;219-226.
30. Roselli-Rehfuss L., Mountjoy K.G., Robbins L.S., Mortrud M.T., Low M.J., Tatro J.B., Entwistle M.L., Simerly R.B., Cone R.D. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. U.S.A. 90:1993;8856-8860.
31. Schiöth H.B., Muceniece R., Mutulis F., Prusis P., Lindeberg G., Sharma S.D., Hruby V.J., Wikberg J.E. Selectivity of cyclic [d-Nal7] and [d-Phe7] substituted MSH analogues for the melanocortin receptor subtypes. Peptides. 18:1997;1009-1013.
32. 4 receptor selective MSH analogues. Br. J. Pharmacol. 124:1998;75-82.
33. Spanagel R., Almeida O.F., Bartl C., Shippenberg T.S. Endogenous kappa-opioid systems in opiate withdrawal: Role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacology (Berlin). 115:1994;121-127.
34. Spanagel R., Herz A., Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. U.S.A. 89:1992;2046-2050.
35. Szekely J.I., Miglecz E., Dunai-Kovacs Z., Tarnawa I., Ronai A.Z., Graf L., Bajusz S. Attenuation of morphine tolerance and dependence by alpha-melanocyte stimulating hormone (alpha-MSH). Life Sci. 24:1979;1931-1938.
36. Terenius L. Effect of peptides and amino acids on dihydromorphine binding to the opiate receptor. J. Pharm. Pharmacol. 27:1975;450-452.
37. Terenius L. Somatostatin and ACTH are peptides with partial antagonist-like selectivity for opiate receptors. Eur. J. Pharmacol. 38:1976;211-213.
38. Terenius L., Gispen W.H., De Wied D. ACTH-like peptides and opiate receptors in the rat brain: Structure-activity studies. Eur. J. Pharmacol. 33:1975;395-399.
39. Thiele T.E., van Dijk G., Yagaloff K.A., Fisher S.L., Schwartz M., Burn P., Seeley R.J. Central infusion of melanocortin agonist MTII in rats: Assessment of c-Fos expression and taste aversion. Am. J. Physiol. 274:1998;248-254.
40. van Ree J.M., Bohus B., Csontos K.M., Gispen W.H., Greven H.M., Nijkamp F.P., Opmeer F.A., de Rotte G.A., van Wimersma Greidanus T.B., Witter A., de Wied D. Behavioral profile of gamma-MSH: Relationship with ACTH and beta-endorphin action. Life Sci. 28:1981;2875-2878.
41. Vergoni A.V., Bertolini A., Mutulis F., Wikberg J.E., Schiöth H.B. Differential influence of a selective melanocortin MC4 receptor antagonist (HS014) on melanocortin-induced behavioral effects in rats. Eur. J. Pharmacol. 362:1998;95-101.
42. Vincent S., Hökfelt T., Christensson I., Terenius L. Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway. Eur. J. Pharmacol. 85:1982;251-252.
43. Volpicelli J.R., Alterman A.I., Hayashida M., O'Brien C.P. Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry. 49:1992;876-880.
44. Wikberg J.E., Muceniece R., Mandrika I., Prusis P., Lindblom J., Post C., Skottner A. New aspects on the melanocortins and their receptors. Pharmacol. Res. 42:2000;393-420.
45. Williams D.L., Kaplan J.M., Grill H.J. The role of the dorsal vagal complex and the vagus nerve in feeding effects of melanocortin-3/4 receptor stimulation. Endocrinology. 141:2000;1332-1337.
46. Xia Y., Wikberg J.E., Chhajlani V. Expression of melanocortin 1 receptor in periaqueductal gray matter. Neuroreport. 6:1995;2193-2196.
47. Yoshimoto K., McBride W.J., Lumeng L., Li T.K. Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol. 9:1992;17-22.